PT141- 10mg
PT-141 (Bremelanotide) — 10 mg
B's Research Labs PT-141, also known as Bremelanotide, is a synthetic cyclic heptapeptide belonging to the melanocortin peptide family. It is structurally related to Melanotan-II and is recognized as a metabolite of that compound. Its molecular structure, Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, contains a cyclic peptide sequence with a free C-terminal carboxylic acid. This structural characteristic distinguishes PT-141 from Melanotan-II, which contains a C-terminal amide group.
These molecular similarities make PT-141 a compound of interest in peptide chemistry, molecular biology, receptor-binding studies, and biochemical research involving melanocortin signaling pathways. Supplied in a 10 mg lyophilized powder format, PT-141 is intended exclusively for controlled laboratory research and analytical applications. Laboratory investigations may focus on peptide stability, molecular structure, receptor-binding characteristics, biochemical interactions, and compound behavior under controlled experimental conditions. Research involving PT-141 may also examine interactions with the five melanocortin receptor subtypes, MC1R through MC5R, with particular scientific interest in MC3R and MC4R signaling pathways. Comparative investigations involving PT-141 and Melanotan-II may explore how differences in terminal functional groups influence receptor interactions, molecular recognition, and peptide-mediated cellular signaling.
These investigations do not establish the safety, efficacy, or suitability of this research product for clinical applications.
Related Research Compounds
PT-141 belongs to a broader group of melanocortin-related research peptides available through B's Research Labs, including Melanotan-I, Melanotan-II, and KPV.
These compounds may be investigated in comparative laboratory studies involving peptide structure, melanocortin-associated molecular pathways, receptor interactions, and biochemical signaling mechanisms. Their molecular structures and biological activities are not identical.
RUO — RESEARCH USE ONLY
For in vitro laboratory research and analytical applications only.
NOT FOR HUMAN OR VETERINARY USE. NOT FOR CONSUMPTION, INJECTION, INGESTION, OR CLINICAL ADMINISTRATION.
Not intended for diagnostic, therapeutic, pharmaceutical, cosmetic, or personal use. No claims are made regarding safety, efficacy, or suitability for human or animal applications.
Compound Identification
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide melanocortin analogue with the molecular sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH, investigated in molecular and biochemical research involving melanocortin receptor interactions and associated cellular signaling pathways.
Catalog note: PT-141 is also the active ingredient in an FDA-approved prescription medication. A research-use-only label does not, by itself, establish that marketing or selling a product is legally compliant. The product's regulatory status and any promotional claims should be reviewed before publication.